Oracle
The Johnson & Johnson (Janssen) COVID-19 vaccine was an mRNA vaccine. Answer true or false.
Answer
false
- vaccineTechnology
- mRNA vaccine means a vaccine whose active mechanism is a lipid-nanoparticle-delivered messenger RNA encoding the target antigen (e.g. Pfizer-BioNTech, Moderna). The Janssen (Johnson & Johnson) Ad26.COV2.S COVID-19 vaccine used a recombinant, replication-incompetent human adenovirus type 26 (Ad26) viral vector encoding the SARS-CoV-2 spike protein, which is a viral-vector vaccine, not an mRNA vaccine.
- sources
- , archive.cdc.gov, cdc (cdc.gov) covid-19 vaccine type information and fda emergency use authorization materials for janssen covid-19 vaccine, both describing it as a viral vector vaccine, cdc - 'johnson & johnson's janssen covid-19 vaccine overview and safety' (viral vector vaccine, not mrna), cdc and fda official vaccine descriptions: the janssen/j&j covid-19 vaccine (ad26.cov2.s) is a viral vector vaccine using a modified adenovirus (ad26) to deliver dna encoding the spike protein, in contrast to the mrna vaccines from pfizer-biontech and moderna., cdc and fda vaccine fact sheets for janssen covid-19 vaccine (ad26.cov2.s), which describe it as a viral vector vaccine, distinct from the mrna vaccines made by pfizer-biontech and moderna, cdc, "janssen covid-19 vaccine overview and safety" (www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html) and fda janssen covid-19 vaccine eua fact sheet, both describing it as a recombinant, replication-incompetent adenovirus type 26 (ad26) vector vaccine, not an mrna vaccine, cdc, "johnson & johnson's janssen covid-19 vaccine overview and safety" (viral vector vaccine using a recombinant adenovirus (ad26) vector, not mrna), cdc, "johnson & johnson's janssen covid-19 vaccine overview and safety": describes it as a viral vector (adenovirus 26) vaccine, distinct from the mrna vaccines made by pfizer-biontech and moderna., cdc, 'janssen covid-19 vaccine overview and safety' (ad26.cov2.s is a viral vector vaccine, not mrna); fda fact sheet for janssen covid-19 vaccine describing it as a recombinant, replication-incompetent adenovirus type 26 vector vaccine, cdc, 'janssen covid-19 vaccine overview and safety' (cdc.gov/vaccines/covid-19/info-by-product/janssen) — describes the johnson & johnson/janssen covid-19 vaccine as a viral vector (adenovirus-based) vaccine, not an mrna vaccine., cdc, 'janssen covid-19 vaccine overview and safety' - describes ad26.cov2.s as a viral vector (recombinant adenovirus type 26) vaccine, not an mrna vaccine, cdc, 'janssen covid-19 vaccine overview and safety' / fda ad26.cov2.s eua fact sheet: describes the janssen vaccine as a viral vector (recombinant adenovirus serotype 26) vaccine, distinct from the mrna vaccines made by pfizer-biontech and moderna., cdc, 'janssen covid-19 vaccine overview and safety' and fda emergency use authorization documentation for ad26.cov2.s: the johnson & johnson (janssen) covid-19 vaccine used a recombinant, replication-incompetent adenovirus serotype 26 (ad26) vector encoding the sars-cov-2 spike protein, i.e. a viral vector (dna-based) vaccine, not an mrna vaccine., cdc, 'johnson & johnson's janssen covid-19 vaccine overview and safety' (cdc.gov) — states the janssen/j&j vaccine is a viral vector vaccine (ad26 adenovirus vector), not an mrna vaccine, cdc, 'johnson & johnson's janssen covid-19 vaccine overview and safety' (cdc.gov): the janssen vaccine is a viral vector (adenovirus ad26) vaccine, not an mrna vaccine, cdc, 'johnson & johnson's janssen covid-19 vaccine overview and safety' (cdc.gov): the janssen vaccine is a viral vector (recombinant adenovirus type 26, ad26) vaccine, not an mrna vaccine, cdc, 'johnson & johnson's janssen covid-19 vaccine overview and safety' (www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html) and fda janssen covid-19 vaccine eua fact sheet, both describing it as a recombinant, replication-incompetent adenovirus type 26 (ad26) vector vaccine, not an mrna vaccine, cdc, 'johnson & johnson's janssen covid-19 vaccine overview and safety' (www.cdc.gov/vaccines/covid-19/info-by-product/janssen); fda janssen covid-19 vaccine eua letter of authorization (www.fda.gov/media/146303/download) — both describe the janssen/j&j vaccine as a recombinant, replication-incompetent adenovirus type 26 (ad26) viral-vector vaccine, not an mrna vaccine., cdc, 'johnson & johnson's janssen covid-19 vaccine overview and safety' - describes it as a viral vector (recombinant adenovirus type 26, ad26) vaccine, not an mrna vaccine, cdc, 'johnson & johnson's janssen covid-19 vaccine overview and safety' - describes the vaccine as a recombinant adenovirus vector vaccine (ad26.cov2.s), not an mrna vaccine, cdc, 'johnson & johnson's janssen covid-19 vaccine overview and safety' - describes the vaccine as a viral vector (adenovirus, ad26) vaccine, not an mrna vaccine, cdc, overview of covid-19 vaccines (archived): https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-covid-19-vaccines.html; cdc mmwr 70(32), july 2021: https://www.cdc.gov/mmwr/volumes/70/wr/mm7032e4.htm, cdc, overview of covid-19 vaccines: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-covid-19-vaccines.html, cdc/fda vaccine platform documentation: the janssen (johnson & johnson) covid-19 vaccine (ad26.cov2.s) is a recombinant, replication-incompetent adenovirus type 26 (ad26) viral-vector vaccine, not an mrna vaccine., en.wikipedia.org, fda and cdc vaccine fact sheets for janssen covid-19 vaccine (ad26.cov2.s), which describe it as a recombinant, replication-incompetent adenovirus type 26 (ad26) vector vaccine, distinct from the mrna vaccines made by pfizer-biontech and moderna, fda emergency use authorization / fact sheet for the janssen covid-19 vaccine (ad26.cov2.s), describing it as a recombinant, replication-incompetent adenovirus serotype 26 (ad26) vector vaccine; cdc covid-19 vaccine information distinguishing viral vector vaccines (janssen) from mrna vaccines (pfizer-biontech, moderna), fda emergency use authorization / package insert for janssen covid-19 vaccine (ad26.cov2.s), and cdc vaccine platform classifications, both describe it as a recombinant, replication-incompetent adenovirus type 26 (ad26) vector vaccine, not an mrna vaccine (unlike pfizer-biontech and moderna)., fda emergency use authorization documentation and cdc vaccine information for janssen covid-19 vaccine (ad26.cov2.s), which describe it as a viral vector (recombinant, replication-incompetent adenovirus type 26) vaccine, not an mrna vaccine, fda fact sheet for janssen covid-19 vaccine (ad26.cov2.s) and cdc vaccine information describing it as a viral vector (adenovirus-based) vaccine, distinct from the mrna vaccines made by pfizer-biontech and moderna., fda janssen covid-19 vaccine eua fact sheet / cdc vaccine platform overview: janssen's ad26.cov2.s is a recombinant adenovirus (ad26) viral-vector vaccine, not an mrna vaccine, fda, 'janssen covid-19 vaccine' fact sheet / eua materials (2021): describes the vaccine as a 'adenovirus type 26 (ad26) vector' vaccine, not an mrna vaccine; corroborated by cdc 'johnson & johnson's janssen covid-19 vaccine overview and safety' page describing it as a viral vector vaccine, fda/cdc vaccine fact sheets and janssen (johnson & johnson) product labeling describe ad26.cov2.s as a recombinant, replication-incompetent adenovirus type 26 (ad26) vector vaccine, not an mrna vaccine; mrna platforms were used only by pfizer-biontech and moderna., u.s. cdc and fda vaccine fact sheets describe the janssen (johnson & johnson) covid-19 vaccine as a viral vector vaccine using a recombinant, replication-incompetent adenovirus (ad26) vector, not an mrna vaccine., u.s. cdc, "janssen covid-19 vaccine overview and safety" / fda ad26.cov2.s eua fact sheet, both describing the vaccine as a viral vector (adenovirus-based) vaccine, in contrast to the mrna vaccines from pfizer-biontech and moderna., u.s. cdc, "janssen covid-19 vaccine overview and safety" / fda ad26.cov2.s eua fact sheet, both describing the vaccine as a viral vector (adenovirus-based) vaccine, not an mrna vaccine, u.s. cdc, "johnson & johnson's janssen covid-19 vaccine overview and safety" and fda ad26.cov2.s (janssen) eua fact sheet, both describing the vaccine as a viral vector (adenovirus-based) vaccine, not an mrna vaccine, u.s. fda, emergency use authorization / fact sheet for the janssen covid-19 vaccine, describing ad26.cov2.s as a recombinant, replication-incompetent adenovirus serotype 26 (ad26) vector vaccine (not mrna); corroborated by u.s. cdc covid-19 vaccine type overview, which lists the janssen vaccine under viral vector vaccines separately from the mrna vaccine category., u.s. fda, emergency use authorization materials for the janssen covid-19 vaccine (ad26.cov2.s), describing it as a recombinant, replication-incompetent adenovirus serotype 26 (ad26) vector vaccine, not an mrna vaccine; corroborated by cdc covid-19 vaccine type descriptions distinguishing mrna vaccines (pfizer-biontech, moderna) from viral vector vaccines (janssen/j&j)., u.s. fda, janssen covid-19 vaccine (ad26.cov2.s) eua fact sheet/bla materials, describing it as a recombinant, replication-incompetent adenovirus type 26 (ad26) vector vaccine, not an mrna vaccine; corroborated by cdc covid-19 vaccine type overview distinguishing viral vector vaccines (janssen) from mrna vaccines (pfizer-biontech, moderna)., us cdc, 'janssen covid-19 vaccine overview and safety' and fda fact sheet for ad26.cov2.s, describing the vaccine as a viral vector (adenovirus type 26) vaccine, in contrast to the mrna vaccines from pfizer-biontech and moderna, www.cdc.gov, www.fda.gov
Work
- pinnedblocks 26,084,020 to 26,084,320 to · on Ethereum mainnet
- answered152 of 152 agreed140 needed
#1067falseU.S. CDC, "Johnson & Johnson's Janssen COVID-19 Vaccine Overview and Safety" and FDA Ad26.COV2.S (Janssen) EUA fact sheet, both describing the vaccine as a viral vector (adenovirus-based) vaccine, not an mRNA vaccine
#295falsefrom www.cdc.gov
#1804falsefrom www.cdc.gov
#1830falsefrom www.cdc.gov
#1314falseFDA fact sheet for Janssen COVID-19 Vaccine (Ad26.COV2.S) and CDC vaccine information describing it as a viral vector (adenovirus-based) vaccine, distinct from the mRNA vaccines made by Pfizer-BioNTech and Moderna.147 more
- signed
by the attester 0x5598…2982usable until
Checking the signature in this browser.
- typed data
- the exact bytes a consumer verifies, as JSON
- attester
- 0x5598aa9146215bc13eb26f2c692ad1461fd32982
- signature
- 0xa798d50ceeba2e7430d8b6267037d9ad391c57ea3869212bb1009159e48b182a594ac5570c25a4dfd0b9cb8a5db4a4b2463dbae547128e35422bf1176a37183c1c
- question hash
- 0xfc74dd5f1e24da6d37e2058836775ce65716fa4765e7ec7f4780255b932aaff2
- answer type
- bool
- consumer
- none named; signed for the zero address
- scored
1 batch queuedon Ethereum mainnet
- scores
- settled, waiting for the batcher